ok - I'm in a good & happy mood so time for some musing...We are...

ok - I'm in a good & happy mood so time for some musing...

We are sitting at lets say $3, and I'm thinking we'll can get to $20 at the end of the 2020 year , in my ultra bullish view
Why? How?

https://hotcopper.com.au/posts/42188126/single

So, with my back of the envelope calculations - no science, no detailed spreadsheets.

Let's go through these items again:

• GVHD approval $5
• US partnership for CHF add $5
• Row partnership for CHF add $5
• US CLBP partnerships add $3
• Other upside surprises add $3 (e.g. Tasly)
• FOMO add $3

Oh - darn - that's over $20 already - sorry I was wrong

Look how things unfold:

• At $1 the $3 target was a dream
• All of the sudden $5 looks like a rather tame target
• When we get to $7 how will $10 look?
• When we get to $14 how will $20 look?

SP just have a way to surprise us.
MSB is transforming from a research company to commercialisation - we can all see this happening right in front of our eyes
And with this MSB is delivering a paradigm shift in treatment of unmet medical needs
How do you limit the upside of this?

So, I'm thinking we'll can get to $20 at the end of the 2020 year, in my ultra bullish view
I'll drink to that!